Population pharmacokinetic analysis of rimonabant in healthy subjects.

被引：1
|
作者：
Ferron, GM [1 ]
Grandison, M [1 ]
Lockwood, G [1 ]
机构：
[1] Sanofi Aventis, Malvern, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2004.12.058
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P43 / P43
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETIC INTERACTION BETWEEN TEGOPRAZAN AND METRONIDAZOLE/TETRACYCLINE/BISMUTH IN HEALTHY KOREAN SUBJECTS.
    Kim, M.
    Jeong, Y.
    Park, J.
    Moon, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S59 - S59
  • [42] Pharmacokinetic and -dynamic dose linearity of iv r-hirudin in healthy subjects.
    Meyer, BH
    Scholtz, H
    Luus, HG
    Grotsch, H
    Rosenkranz, B
    Friesen, HJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PII20 - PII20
  • [43] The pharmacokinetic interaction between clarithromycin and TMC114/ritonavfr in healthy subjects.
    Sekar, VJ
    Guzman, S
    De Pauw, M
    De Paepe, E
    Vangeneugden, T
    Hoetelmans, R
    Lefebvre, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [44] COMPARISON OF PHARMACOKINETIC AND PHARMACODYNAMIC RESULTS OF ERTUGLIFLOZIN BETWEEN JAPANESE AND WESTERN HEALTHY SUBJECTS.
    Li, Y.
    Nucci, G.
    Yamamoto, Y.
    Sahasrabudhe, V.
    Fediuk, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S82 - S82
  • [45] A pharmacokinetic study of the NMDA receptor antagonist memantine and donepezil in healthy young subjects.
    Periclou, A
    Ventura, D
    Sherman, T
    Rao, N
    Abramowitz, W
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S225 - S225
  • [46] LACK OF A PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND WARFARIN IN HEALTHY SUBJECTS.
    Plowchalk, D. R.
    Qiu, R.
    Terra, S. G.
    Corrigan, B.
    Fang, J.
    Fullerton, T.
    Liu, J.
    Byon, W.
    Mordenti, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S57 - S57
  • [47] Xyrem® (sodium oxybate):: Pharmacokinetic interactions with Provigil® (modafinil) in healthy human subjects.
    Borgen, LA
    Lane, E
    Lai, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P17 - P17
  • [48] SAFETY, TOLERABILITY AND PHARMACOKINETIC CHARACTERISITCS OF VVZ-149 INJECTION IN HEALTHY SUBJECTS.
    Yoon, J.
    Oh, J.
    Kim, Y.
    Cho, S.
    Lee, D.
    Shin, S.
    Jang, I.
    Yu, K.
    Chung, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S72 - S72
  • [49] POPULATION PHARMACOKINETIC (PK) AND PHARMACOKINETIC-PHARMACODYNAMIC (PK/PD) ASSESSMENT OF GDC-0334 (A TRPA1 INHIBITOR) IN HEALTHY SUBJECTS.
    Chan, H.
    Li, H.
    Liu, L.
    Ding, H.
    Ferl, G.
    Bauer, R.
    Gao, S.
    Joseph, V.
    Yang, X.
    Quartino, A.
    Putnam, W.
    Pan, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S98 - S98
  • [50] Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease
    Knebel, William
    Rao, Niranjan
    Uchimura, Tatsuo
    Mori, Akihisa
    Fisher, Jeannine
    Gastonguay, Marc R.
    Chaikin, Philip
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 40 - 52
12345